Kiniksa Pharmaceuticals, Ltd. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $90.73 | $2.72 B | -49.3 | 130 | $110.32 M |
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.58 | $29.02 M | -0.46 | 100 | $7.88 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $12.69 | $1.29 B | -7.16 | 85 | $0 |
 CHRS
|
Coherus BioSciences, Inc. | $1.08 | $193.89 M | -2.28 | 235 | $257.24 M |
 COGT
|
Cogent Biosciences, Inc. | $9.21 | $802.20 M | -3.37 | 164 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.80 | $1.12 B | -5.11 | 174 | $0 |
 GOSS
|
Gossamer Bio, Inc. | $0.70 | $124.06 M | -0.65 | 135 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $32.96 | $2.47 B | -23.59 | 136 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 KRON
|
Kronos Bio, Inc. | $0.90 | $44.62 M | -0.37 | 58 | $6.29 M |
 KRTX
|
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 |
 KURA
|
Kura Oncology, Inc. | $10.85 | $1.66 B | -10.03 | 142 | $0 |
 LRMR
|
Larimar Therapeutics, Inc. | $6.30 | $611.84 M | -9.99 | 42 | $0 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.19 | $19.53 M | -0.27 | 88 | $1.56 M |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 NUVL
|
Nuvalent, Inc. | $95.10 | $5.11 B | -32.72 | 127 | $0 |
 NVCT
|
Nuvectis Pharma, Inc. | $4.77 | $116.38 M | -4.5 | 13 | $0 |
 PHAT
|
Phathom Pharmaceuticals, Inc. | $9.72 | $620.47 M | -2.38 | 452 | $682,000 |
 REPL
|
Replimune Group, Inc. | $15.96 | $485.18 M | -2.44 | 331 | $0 |
 SPRO
|
Spero Therapeutics, Inc. | $1.15 | $75.85 M | 3.19 | 46 | $96.74 M |
 VTYX
|
Ventyx Biosciences, Inc. | $1.79 | $229.83 M | -1.01 | 75 | $0 |